Showing posts with label Flaviviruses. Show all posts
Showing posts with label Flaviviruses. Show all posts

Wednesday, February 3, 2016

All about Zika virus infection.



Zika Virus was first isolated from rhesus monkeys  in Zika forest in Uganda in 1947, but was barely in news till now as it did not cause outbreak in humans.

The Zika virus is a flavivirus, part of the same family as yellow fever, West Nile, chikungunya and dengue. But unlike some of those viruses, there is no vaccine to prevent Zika or medicine to treat the infection.

The incubation period of Zika virus disease is not clear, but is likely to be a few days. The symptoms are similar to other arbovirus infections such as dengue, and include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. These symptoms are usually mild and last for 2-7 days. But, majority of patients with this infection have no or very little symptoms, causing it very difficult to track. They can, however, still transmit the disease if they are bitten by a mosquito that then bites someone else.

Transmission
The Vector for Zika is  Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours. On Tuesday CDC reported the first sexually transmitted case of Zika virus in Dallas, Texas.  Previously, there have been only two documented cases linking Zika to sex and isolated cases of spread through blood transfusion.
In addition, the CDC says there have been documented cases of virus transmission during labor( vertical transmission ) , blood transfusion, and laboratory exposure. While Zika has been found in breast milk, it's not yet confirmed it can be passed to the baby through nursing.

Diagnosis
According to CDC- During the first week of illness, Zika virus disease can often be diagnosed by performing reverse transcriptase-polymerase chain reaction (RT-PCR) on serum. Serology assays can also be used to detect Zika virus-specific IgM and neutralizing antibodies, which typically develop toward the end of the first week of illness. Plaque-reduction neutralization testing (PRNT) can be performed to measure virus-specific neutralizing antibodies to confirm primary flavivirus infections and differentiate from other viral illnesses.


World Health Organization Director-General Margaret Chan declared the current outbreak as  a public health emergency on February 1, 2016, with 24 countries involved from South and Central America and the Caribbean involved in the outbreak.

Courtesy: Vox.com


Zika is commanding attention worldwide because of connection between the virus and microcephaly.


According to CDC, in the past four months, microcephaly cases in Brazil rocketed to 3,500 from 147, the average for the same time last year (2014).  About 46 babies have died due to birth defects.

The link was first detected when Brazilian health authorities found traces of the Zika virus in a deceased infant born with microcephaly or in amniotic fluid of mothers delivering microcephalic infants.

The first confirmed cases of ZIKV infection in Brazil were reported in May 2015.

Transmission of the virus in Brazil is likely to have started several months before because the disease is new and mild, and could have been unrecognised or misdiagnosed, as dengue and chikungunya epidemics were ongoing.

Microcephaly caused due to any infection is usually caused by transplacental infections occurring early in pregnancy and is only detected during the second half of pregnancy or after birth.

The observed six months delay between the recognition of the transmission of ZIKV in May 2015, and the detection of an increase in microcephaly in November 2015, is therefore compatible with a temporal association between the two events.

Currently there is only ecological evidence of an association between the two events, due to sudden epidemic of microcephalic babies born and clustered around a specific time period. Researchers are still working to confirm the link — could it be something else that's causing the microcephaly?

On 13 January 2016, the Brazil Ministry of Health reported the detection of Zika virus genome, through the RT-PCR technique in four cases of congenital malformation in the state of Rio Grande do Norte. The cases correspond to two miscarriages and two full-term newborns (37 and 42 weeks respectively) who died in the first 24 hours of life. Tissue samples from both newborns were also positive for Zika virus by immunohistochemistry

Obstetrical providers should obtain a travel history from all pregnant women and use recent travel history to guide decisions about testing.  Testing is not indicated for pregnant women without a travel history to an area with Zika virus transmission.

Courtesy: Vox.com


Diagnosis in pregnant patients.
Zika virus RT-PCR can also be performed on amniotic fluid.  Other testing that can performed includes the following: 1) histopathologic examination and immunohistochemical staining of the placenta and umbilical cord, 2) Zika virus testing of frozen placental tissue and cord tissue, and 3) IgM and neutralizing antibody testing of cord blood.

Amniocentesis should be offered to pregnant women with recent travel to an area with Zika virus transmission, reporting 2 or more symptoms within two weeks of travel and a positive or inconclusive maternal serum test.  For pregnant women with recent travel to an area with Zika virus transmission and ultrasound findings of microcephaly or intracranial calcifications, amniocentesis may also be considered.

A positive Zika virus RT-PCR result from amniotic fluid would be suggestive of intrauterine infection.  This information would be useful for pregnant women and their healthcare providers to assist in determining clinical management (e.g., antepartum testing, delivery planning).  A negative Zika virus RT-PCR result from amniotic fluid may prompt a work up for other causes of microcephaly (e.g., other infections, genetic disorders).

There is currently no cure for the Zika virus. A number of institutions are scrambling to develop a vaccine, but it could take up to five years, as health experts called for new incentives for drug companies.

Meanwhile, American women who are pregnant have been advised to stay out of countries where the Zika virus is circulating. The CDC recommends consulting your doctor before your trip and following steps to prevent mosquito bites during the trip.



References:
http://www.paho.org/hq/index.php?%20option=com_topics&view=article&id=427&Itemid=41484&lang=en

Sunday, January 17, 2016

Microcephaly in Brazil potentially linked to the Zika virus epidemic says European Center for Disease Control (ECDC).





photo by CDC PHIL, Aedes Mosquito


 
New European Center for Disease Control ( ECDC) risk assessment is currently evaluating a possible link between the observed increase of congenital microcephaly in Brazil and Zika virus (ZIKV) infection.

Until recent months Zika virus was not widely associated with microcephaly.

According to CDC, in the past four months, microcephaly cases in Brazil rocketed to 3,500 from 147, the average for the same time last year (2014).  About 46 babies have died due to birth defects.

The link was first detected when Brazilian health authorities found traces of the Zika virus in a deceased infant born with microcephaly or in amniotic fluid of mothers delivering microcephalic infants.

The first confirmed cases of ZIKV infection in Brazil were reported in May 2015.

Transmission of the virus in Brazil is likely to have started several months before because the disease is new and mild, and could have been unrecognised or misdiagnosed, as dengue and chikungunya epidemics were ongoing.

Microcephaly caused due to any infection is usually caused by transplacental infections occurring early in pregnancy and is only detected during the second half of pregnancy or after birth.

The observed six months delay between the recognition of the transmission of ZIKV in May 2015, and the detection of an increase in microcephaly in November 2015, is therefore compatible with a temporal association between the two events.

Currently there is only ecological evidence of an association between the two events, due to sudden epidemic of microcephalic babies born and clustered around a specific time period.

A possible causative association cannot be ruled out but further investigations and studies are needed to understand the association and the possible role of other factors, states the ECDC risk assessment.

In November the Brazilian Ministry of Health declared a public health emergency in relation to an unusual increase in the number of children born with microcephaly in 2015.

In addition to Brazil's findings, French Polynesian health authorities have also reported an unusual increase in autoimmune and central nervous system malformations in babies born during a Zika virus outbreak on the islands from 2014 to 2015. (73 cases, 42 of them being Guillain-Barré Syndrome, in a population of about 270 000). 

CDC map illustrates areas affected or possibly affected by the spread of Zika virus


Zika virus disease is a mosquito-borne viral disease caused by Zika virus (ZIKV), a flavivirus from the Flaviviridae family and is primarily transmitted through the bite of infected Aedes mosquitoes.

The virus was first identified in 1947 in the Zika forest in Uganda in the rhesus Macaque population and have two main lineages, the African lineage and the Asian lineage.

Prenatal or perinatal complications of ZIKV infections have not been described in the literature. There is some evidence that perinatal transmission can occur, most probably transplacental or during the delivery of a viraemic mother. However, materno-foetal transmission has been demonstrated for several other Flaviviruses (dengue, West Nile fever).

Some other Flavivirus infections are known to have the potential to cause premature birth, congenital defects and microcephaly.

The most common symptoms of Zika virus disease are fever, rash, joint pain, and conjunctivitis (red eyes). The illness is usually mild with symptoms lasting from several days to a week.

Meanwhile, Brazilian officials are also reporting neurologic complications in other Zika virus patients, primarily Guillain-Barre syndrome, which has also been seen in French Polynesian patients who had suspected infections. "Although neither even establishes a causal relation with Zika virus, the hypothesis cannot be ruled out," says a health official in Brazil.

In conclusion, a causative association between microcephaly in newborns and ZIKV infection during pregnancy is plausible, but not enough evidence is available yet to confirm or refute it. Many studies are needed before a definite conclusion can be reached.

There is no vaccine to prevent infection or medicine to treat Zika virus.

Meanwhile, CDC issues a travel advisory to pregnant women  to consider postponing travel to areas where Zika virus transmission is ongoing.




References: